For pharmaceutical investment companies, what exactly pharmaceutical investment promotion does, in fact, the key is to look at the loyalty of drug agents. Customer loyalty is also related to the recognition of ideas between customers and enterprises. This is especially true for service-oriented companies. This concept recognition is not only for the enterprise product design and production concept, but more importantly for the company's brand concept and service concept. The customer's high level of loyalty to the company is often the customer's recognition of the concept of the level of the company, the customer is often because of the recognition of the company's philosophy will have to support the action of pharmaceutical investment companies.

First, SMEs that use marketing channel management models for pharmaceutical investment promotion should pay attention to drug agency relationship management, invest the necessary time and energy to create opportunities and platforms for cooperation with distributors, and establish customer information, files and clubs to communicate with distributors at any time. Concerned about the dynamics of distributors to ensure smooth sales channels. In China's pharmaceutical market, there are many drug manufacturers and commercial enterprises that form alliances in the form of strategic cooperation. An important part of their successful cooperation is the provision of products by one party and sales channels by the other party.

Secondly, for pharmaceutical investment enterprises, in the majority of markets, these individual agents with abundant local resources and contacts are the main partners. In addition to the establishment of a suitable business relationship, due to limitations in the company’s own products, strengths, and networks, a considerable number of companies cannot effectively implement the excavation and development of individual agents, so it may be possible to change their thinking and not effectively cover the product. The region relied on local commercial companies to implement the development of regional drug agents.

Finally, in the pharmaceutical investment industry, customer loyalty is fundamental to maintaining long-term profitability and winning a competitive advantage. Customer loyalty is usually associated with the quality of service, service experience, relationship interaction, concept recognition and value increase perceived by the customer's perspective. It promotes the development of customer loyalty and enables the company to succeed. The best strategy is to transfer the eligibility of these terminals to local customers with certain cooperation intentions, so as to reach a deeper level of market development with customers.